POMC and neoplasm: We used 36 clinical markers as the predictor variables for subtype prediction, derived from AST, DST, and CCT, which may reflect responsiveness to ACTH or Renin-Angiotensin, tumor information obtained from CT-imaging (see the detail in the “Methods” section “Training classifiers”) besides demographic and common biochemical data.